We are live on
!
Find out more
SSA
Schonfeld Strategic Advisors Portfolio holdings
AUM
$14.2B
1-Year Est. Return
37.17%
This Fund
S&P 500
This Quarter
Est. Return
+11.58%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.75%
5 Year Est. Return
+136.39%
10 Year Est. Return
+833.52%
AUM
$1.84B
AUM Growth
+$512M
(+38%)
Cap. Flow
+$511M
Cap. Flow
% of AUM
27.7%
Top 10 Holdings %
Top 10 Hldgs %
9.81%
Holding
1,111
New
387
Increased
195
Reduced
145
Closed
373
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equitable Holdings
EQH
|
+$23M |
| 2 |
FPAC.U
Far Point Acquisition Corporation Units, each consisting of one share of Class A common stock, $0.00
FPAC.U
|
+$22.4M |
| 3 |
Sherwin-Williams
SHW
|
+$15.8M |
| 4 |
Merck
MRK
|
+$15.1M |
| 5 |
Norfolk Southern
NSC
|
+$11.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$23.7M |
| 2 |
DuPont de Nemours
DD
|
+$15.1M |
| 3 |
Wynn Resorts
WYNN
|
+$12.7M |
| 4 |
NVIDIA
NVDA
|
+$9.64M |
| 5 |
Cigna
CI
|
+$9.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.83% |
| 2 | Consumer Discretionary | 15.68% |
| 3 | Financials | 12.95% |
| 4 | Industrials | 12.38% |
| 5 | Technology | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Tandem Diabetes Care
TNDM
$1.17B
| $22.8M | 1.24% |
1,036,600
+36,600
| +4% | +$450K |
|
|
FPAC.U
2
DELISTED
Far Point Acquisition Corporation Units, each consisting of one share of Class A common stock, $0.00
FPAC.U
| $22.4M | 1.22% |
+2,200,000
| New | +$22.4M |
|
|
3
Equitable Holdings
EQH
$13.1B
| $22.3M | 1.21% |
+1,082,300
| New | +$23M |
|
|
4
Sherwin-Williams
SHW
$78.3B
| $20.1M | 1.09% |
147,594
+122,280
| +483% | +$15.8M |
|
5
Amazon
AMZN
$2.5T
| $19.3M | 1.05% |
226,900
-41,880
| -16% | -$3.32M |
|
|
6
Merck
MRK
$324B
| $16.5M | 0.89% |
284,080
+268,217
| +1,691% | +$15.1M |
|
7
Visa
V
$677B
| $16.3M | 0.88% |
122,878
+57,399
| +88% | +$7.39M |
|
|
TPGH.U
8
DELISTED
TPG Pace Holdings Corp. Units, each consisting of one Class A ordinary share, $.0001 par value, and
TPGH.U
| $15.8M | 0.85% |
1,500,000
| – | – |
|
9
Sarepta Therapeutics
SRPT
$1.66B
| $12.8M | 0.7% |
97,100
+88,438
| +1,021% | +$8.34M |
|
|
BRSL
10
Brightstar Lottery PLC
BRSL
$1.91B
| $12.7M | 0.69% |
545,147
+233,964
| +75% | +$6.23M |
|
11
Boston Scientific
BSX
$65.8B
| $12.5M | 0.68% |
380,882
+53,488
| +16% | +$1.61M |
|
12
Morgan Stanley
MS
$337B
| $12.4M | 0.67% |
261,764
+193,698
| +285% | +$10.1M |
|
|
13
Norfolk Southern
NSC
$78.8B
| $11.9M | 0.65% |
79,042
+77,372
| +4,633% | +$11.3M |
|
14
CME Group
CME
$92.2B
| $11.6M | 0.63% |
70,797
-25,124
| -26% | -$4.1M |
|
|
GWPH
15
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $11.4M | 0.62% |
81,600
+19,329
| +31% | +$2.75M |
|
16
American Express
AXP
$223B
| $11.2M | 0.61% |
114,043
+80,740
| +242% | +$7.93M |
|
17
Wells Fargo
WFC
$261B
| $11M | 0.6% |
198,709
+145,460
| +273% | +$7.79M |
|
18
Bio-Rad Laboratories Class A
BIO
$8.42B
| $10.8M | 0.59% |
37,512
+35,989
| +2,363% | +$9.94M |
|
19
Ametek
AME
$55.5B
| $10.6M | 0.57% |
146,778
+19,669
| +15% | +$1.46M |
|
|
GSAH.U
20
DELISTED
GS Acquisition Holdings Corp. Units, each consisting of one share of Class A common stock and one-th
GSAH.U
| $10.5M | 0.57% |
+1,028,100
| New | +$10.5M |
|
21
Idexx Laboratories
IDXX
$42.9B
| $10.5M | 0.57% |
48,011
+26,439
| +123% | +$5.45M |
|
|
SIEN
22
DELISTED
Sientra, Inc.
SIEN
| $10.5M | 0.57% |
53,624
+13,624
| +34% | +$2.16M |
|
23
Emerson Electric
EMR
$82.9B
| $10.3M | 0.56% |
148,466
+71,019
| +92% | +$4.99M |
|
|
FSACU
24
DELISTED
Federal Street Acquisition Corp. Unit
FSACU
| $10.2M | 0.55% |
1,000,000
| – | – |
|
25
Constellation Brands
STZ
$22.2B
| $10.2M | 0.55% |
46,525
+35,418
| +319% | +$8M |
|
Similar funds
FGP
BBVA
IFP
BIP
X
CM
Schonfeld Strategic Advisors's Q2 2018 Portfolio in Review
As of Q2 2018, Schonfeld Strategic Advisors held 1,111 positions worth $1.84B, up 38% from $1.33B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Schonfeld Strategic Advisors deployed $511M of net new capital in Q2 2018, opening 387 new positions and adding to 195 existing holdings. Its largest new stake was Equitable Holdings: 1,082,300 shares worth $22.3M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Wynn Resorts, an estimated $12.7M trimmed.
- Schonfeld Strategic Advisors's largest Q2 2018 buy was Equitable Holdings: 1,082,300 shares worth $22.3M.
- Schonfeld Strategic Advisors added most to Sherwin-Williams in Q2 2018, an estimated $15.8M increase.
- Schonfeld Strategic Advisors's biggest Q2 2018 reduction was Wynn Resorts, cutting an estimated $12.7M.
- Schonfeld Strategic Advisors fully exited Meta Platforms (Facebook) in Q2 2018, selling an estimated $23.7M.
- Schonfeld Strategic Advisors's ten largest holdings make up 9.8% of its $1.84B portfolio in Q2 2018.
- Schonfeld Strategic Advisors opened 387 new positions and closed 373 in Q2 2018.
- Schonfeld Strategic Advisors's portfolio value rose 38% quarter-over-quarter to $1.84B.
Based on Schonfeld Strategic Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.